Have you ever wanted to measure your performance across all audits you’ve conducted? Compare your audit results to the overall industry? Or contrast by region?  How about having metrics to show senior management your weaknesses, but also your strengths as compared to your peers?pie-chart-blockv2


At this year’s 2015 DIA Annual conference, ADAMAS Consulting featured the industry’s only benchmarking service of QA audit findings that gives Sponsors the ability to better compare their audit results to industry averages. For the past five years, ADAMAS has captured de-identified audit variables from the several hundred GCP and GVP audits that we have conducted – creating a database that provides live industry trends with regard to the frequency, criticality and specific observation types per audit on average.

Benefits? Learn where there may be risks with your trial. If you have early identification of variations from the average audit – which may indicate potential risk areas within a clinical study, or auditee – this gives you the opportunity to investigate and remediate study problems with expediency before they become endemic.

ADAMAS now brings this performance management to your oversight activities with the ability to trend and report metrics on GCP and GVP audit findings!

If you would like to learn more about ADAMAS and our services, give us a call at
+1-919-341-3361 or contact Steve Bliss at steve.bliss@adamasconsulting.com.

The ADAMAS Corporate Brochure 2016


Brochure – Please download the ADAMAS brochure describing our QA services and contact details.

Regulatory Environment


The development of medicines is the most regulated industry in the world, and compliance at each stage of the research and development process, as well as after licensing, is critical to ensuring high quality and safe medicines reach patients in a timely manner.



ADAMAS’s consultants have expertise across the G’X’Ps in pre-clinical, clinical and post-licensing areas. They have worked across many different therapeutic areas and product types including oncology, vaccines, biologics, medical devices and gene therapy. As a company we have developed close partnerships with our clients to support them in their development programmes and post-licensing activities, and to guide them successfully through their worldwide regulatory inspections.


How to be a Clinical Auditor


‘So you want to be a Clinical Auditor?’, an article written by CEO Dr. Patricia Fitzgerald.

Benchmarking Data


Please download our benchmarking data sheet, to see how these data compare with your own performance. To discuss a more detailed report, or analysis of a data subset, please get in touch.

Is your QMS compliant?


Is your QMS compliant to the upcoming ICH E6 Addendum? Download our 5-point checklist

ICH (E6) R2 Addendum - Step 4


Please enter your details to complete the download.



Want to become one of the first businesses to access our exclusive data?
Get going and start reducing risk today. Pre register now.